Gonorrhea testing, morbidity, and reporting using an integrated sexually transmitted disease registry in Indiana: 2004–2016

Ojo, Opeyemi C; Arno, Janet N.; Tao, Guoyu; Patel, Chirag G.; Zhang, Zuoyi; Wang, Jane; Holderman, Justin L; Dixon, Brian E.

doi:10.1177/0956462420953718

Cited by 2 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The morbidity of gonorrhea refers to its occurrence and impact within a community. Morbidity measurements shed light on the prevalence, distribution, and burden of gonorrhea cases, aiding in better understanding the public health implications and guiding intervention strategies [ 6 , 10 ].…”

Section: Introductionmentioning

confidence: 99%

“…Gonorrhea poses substantial challenges to public health in the US. In recent years, there has been a concerning increase in antibiotic-resistant strains of Neisseria gonorrhoeae, complicating treatment and control efforts [6][7][8][9][10][11][12][13]. Additionally, certain populations, such as adolescents (10-19 years) and young adults (15-24 years), have been disproportionately affected by gonorrhea, with higher infection rates than other age groups [12].…”

Section: Introductionmentioning

confidence: 99%

“…The availability of extensive health datasets in recent years has facilitated in-depth investigations into the epidemiological patterns and morbidity rates of various health disorders, including sexually transmitted diseases (STDs). The CDC in the US maintains the CDC WONDER (Wide-ranging Online Data for Epidemiologic Research) Underlying Cause of Death Database, which provides national and state-level data on causes of mortality and morbidity, allowing valuable insights into the impact of gonorrhea on public health [8][9][10]. The morbidity of gonorrhea refers to its occurrence and impact within a community.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Epidemiological Trends and Factors Associated With the Morbidity Rate of Gonorrhea: A CDC-WONDER Database Analysis

Akinboro,

Mmaduabuchi,

Beeko

et al. 2023

Cureus

View full text Add to dashboard Cite

Background and objective: Gonorrhea is a prevalent sexually transmitted illness caused by the bacteria Neisseria gonorrhoeae, leading to serious health consequences such as pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and increased susceptibility to HIV infection. Despite advancements in prevention and treatment, gonorrhea remains a significant public health problem in the United States (US) due to its widespread incidence, potential consequences, and the growth of antibiotic resistance. This study investigates the epidemiological trends and morbidity rates of gonorrhea using the Centers for Disease Control and Prevention's (CDC) Wide-ranging Online Data for Epidemiologic Research (WONDER) database. The aim is to identify temporal patterns, demographic characteristics, and notable changes in gonorrhea epidemiology to inform targeted therapies and interventions. Methods: The CDC WONDER database, which provides extensive national and state-level data on reported causes of death in the United States, was utilized for this study. We examined the developments in gonorrhea morbidity rates over time, identified demographic differences based on age, gender, and race/ethnicity, and analyzed the disease's regional distribution through a systematic analysis of the database. Aggregate data for selected time periods (1996-2014) were summarized using the morbidity rate per 100,000 people and the total number of cases across the years. Results: This database analysis identified a total of 6,454,097 individuals diagnosed with gonorrhea between 1996 and 2014. The calculated total morbidity rate during this period was 115.4 per 100,000 individuals. The highest morbidity rates were observed in the years 1999 (129.2 per 100,000 people), 1998 (129.1 per 100,000 people), and 2001 (126.8 per 100,000 people), respectively. The District of Columbia reported the highest morbidity rate (478.25 per 100,000 people). In males, the overall morbidity rate over the years was reported to be comparable to females (114 per 100,000 people and 116.3 per 100,000 people, respectively). The analysis revealed consistently higher morbidity rates among individuals aged between 19 and 24 years (525.2 per 100,000 people). Moreover, black or African American individuals consistently exhibited higher morbidity rates (506.1 per 100,000 people) compared to white individuals (16.1 per 100,000 people). Conclusion: The analysis of gonorrhea cases between 1996 and 2014 revealed that the highest rates occurred during specific years, with a particular concentration observed in the District of Columbia. Additionally, certain demographic groups, such as individuals aged 19-24 and the black or African American population, consistently exhibited higher morbidity rates compared to others. These findings emphasize the importance of targeted interventions to address the observed temporal patterns and demographic disparities, in order to effectively combat the spread of gonorrhea.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological Trends and Factors Associated With the Morbidity Rate of Gonorrhea: A CDC-WONDER Database Analysis

Akinboro,

Mmaduabuchi,

Beeko

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

Syphilis testing adherence among women with livebirth deliveries: Indianapolis 2014-2016

Ojo

Arno

Tao

et al. 2021

BMC Pregnancy Childbirth

Self Cite

View full text Add to dashboard Cite

Background The number of congenital syphilis (CS) cases in the United States are increasing. Effective prevention of CS requires routine serologic testing and treatment of infected pregnant women. The Centers for Disease Control and Prevention (CDC) recommends testing all pregnant women at their first prenatal visit and subsequent testing at 28 weeks gestation and delivery for women at increased risk. Methods We conducted a cross-sectional cohort study of syphilis testing among pregnant women with a livebirth delivery from January 2014 to December 2016 in Marion County, Indiana. We extracted and linked maternal and infant data from the vital records in a local health department to electronic health records available in a regional health information exchange. We examined syphilis testing rates and factors associated with non-testing among women with livebirth delivery. We further examined these rates and factors among women who reside in syphilis prevalent areas. Results Among 21260 pregnancies that resulted in livebirths, syphilis testing in any trimester, including delivery, increased from 71.7% in 2014 to 86.6% in 2016. The number of maternal syphilis tests administered only at delivery decreased from 16.6% in 2014 to 4.04% in 2016. Among women living in areas with high syphilis rates, syphilis screening rates increased from 79.6% in 2014 to 94.2% in 2016. Conclusion Improvement in prenatal syphilis screening is apparent and encouraging, yet roughly 1-in-10 women do not receive syphilis screening during pregnancy. Adherence to recommendations set out by CDC improved over time. Given increasing congenital syphilis cases, the need for timely diagnoses and prevention of transmission from mother to fetus remains a priority for public health.

show abstract

Gonorrhea testing, morbidity, and reporting using an integrated sexually transmitted disease registry in Indiana: 2004–2016

Cited by 2 publications

References 11 publications

Epidemiological Trends and Factors Associated With the Morbidity Rate of Gonorrhea: A CDC-WONDER Database Analysis

Epidemiological Trends and Factors Associated With the Morbidity Rate of Gonorrhea: A CDC-WONDER Database Analysis

Syphilis testing adherence among women with livebirth deliveries: Indianapolis 2014-2016

Contact Info

Product

Resources

About